PROPHASE LABS, INC. (NASDAQ:PRPH) Files An 8-K Financial Statements and Exhibits

0

PROPHASE LABS, INC. (NASDAQ:PRPH) Files An 8-K Financial Statements and Exhibits
Item 9.01 Financial Statements and Exhibits.

(d)Exhibits

Exhibit No. Description
99.1 Press Release dated August 15, 2017


ProPhase Labs, Inc. Exhibit
EX-99.1 2 ex99-1.htm   Exhibit 99.1     PRESS RELEASE   PROPHASE LABS,…
To view the full exhibit click here

About PROPHASE LABS, INC. (NASDAQ:PRPH)

ProPhase Labs, Inc. is a manufacturer, marketer and distributor of a range of homeopathic and health products. The Company is also engaged in the research and development of over-the-counter (OTC) drugs, natural base health products along with supplements, personal care and cosmeceutical products. It is engaged in manufacturing, distributing, marketing and sale of OTC cold remedy products to consumers through national chain, regional, specialty and local retail stores. It also manufactures, markets and distributes an organic cough drop and a Vitamin C supplement, Organix, and performs contract manufacturing services of cough drop, dietary supplements, and other OTC cold remedy products for third parties. Its product pipeline includes Cold-EEZE Cold Remedy QuickMelts and Cold-EEZE Cold Remedy Oral Spray. It also produces Legendz XL for sexual health, Triple Edge XL, which is a daily energy booster plus testosterone support, and Super ProstaFlow Plus for prostate and urinary health.